I-MAK

To read "Medicines Robin Hood: Priti Radhakrishnan gives the poor access to lifesaving drugs", NYU Law Magazine's profile on I-MAK Co-Director, click HERE.

"The use of outside experts for reviewing patents could prevent the granting of unmerited patents and high drug prices in many developing countries. This is the view of Tahir Amin, co-Director of the Initiative for Medicines, Access & Knowledge (I-MAK), which helped prepare a pre-grant patent opposition to Gilead's AIDS treatment, Viread (tenofovir disoproxil fumarate), on behalf of Indian patient groups. Read more.

“Enforcement will dominate everything” in 2009, said Tahir Amin of the Intitiative for Medicines, Access & Knowledge (I-MAK) in New York. The use of the term “counterfeit” in reference to enforcement efforts, with its connotations of trademark law, will be “one of the major battlegrounds.” Read the full story here.

In its latest newsletter, Echoing Green features the founders of I-MAK.

Based in New York, I-MAK harnesses the best legal and scientific talent from across the world to help develop the best case possible to protect the public from companies misusing patent regulations and blocking access to cheap drugs.